Log In
Print this Print this

Valstar, valrubicin

Also known as: Valtaxin (AD32)

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionLipophilic anthracycline analog
Molecular Target DNA
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBladder cancer
Indication DetailsAdvanced superficial carcinoma of the bladder; Treat carcinoma in situ (CIS) of the bladder; Treat refractory carcinoma in situ (CIS) of the bladder
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today